Business

TOPVISION Eye Specialist Berhad officially debuts ACE Market of Bursa Malaysia with 18.18% premium

From L-R:
Ms. Lim May Wan, Independent Non-Executive Director, TOPVISION Eye Specialist Berhad
Ms. Soong Yoke Voon, Chief Operating Officer, TOPVISION Eye Specialist Berhad
Dr. Peter Chong Kuok Siong, Chief Executive Officer and Executive Director, TOPVISION Eye Specialist Berhad
Mr. Lee Geok Ai, Independent Non-Executive Chairman, TOPVISION Eye Specialist Berhad
Datuk Kenny Liew Hock Nean, Executive Vice Chairman, TOPVISION Eye Specialist Berhad
Professor Datin Dr. Angela Loo Voon Pei, Consultant Ophthalmologist, TOPVISION Eye Specialist Berhad
Ms. Tan Mei Hui, Chief Financial Officer, TOPVISION Eye Specialist Berhad
Mr. Tan Kah Poh, Independent Non-Executive Director, TOPVISION Eye Specialist Berhad

TOPVISION Eye Specialist Berhad (TOPVISION) has officially transfer of listing today on the ACE Market of Bursa Malaysia Securities Berhad (Bursa Securities). TOPVISION shares debuted at RM0.390 per share, reflecting a 18.18% premium over its issue price of RM0.330.

TOPVISION is listed under the stock name “TOPVISN” with the stock code “0332”.

As one of the pioneer in accessible and advanced eye care services which was listed on the LEAP Market in 2018, TOPVISION has established itself as a trusted provider in Malaysia’s healthcare landscape. The Company operates 11 ambulatory care centres (ACCs) nationwide, offering a wide range of services from general eye care to subspecialty treatments, catering to both local and international patients.

The successful public offering raised RM17.9 million, which will be strategically allocated to support the Company’s expansion and operational goals. Specifically, RM7.9 million will be used to fund the development of TOPVISION International, a multidisciplinary specialist tertiary eye ACC with an additional RM5.0 million to be allocated for the establishment of TOPVISION Kuala Terengganu and TOPVISION Tawau, while RM0.5 million is set aside for enhancing existing facilities via purchase of medical machines. The remaining RM4.5 million has been allocated for listing expenses.

Datuk Kenny Liew Hock Nean, Executive Vice Chairman of TOPVISION, shared his enthusiasm, stating, “This transfer of listing marks a significant milestone in TOPVISION’s journey, reflecting our unwavering commitment to delivering quality and accessible eye care services across Malaysia. It symbolises not only the culmination of our hard work but also the confidence the market has in our strategic vision and growth potential. With this transition, we aim to strengthen our presence in Malaysia’s eye healthcare sector, expand our service network, and elevate the standards of patient care to new heights.”

Hong Leong Investment Bank Berhad is the Principal Adviser, Sponsor, Sole Underwriter and Sole Bookrunner.

Drop some comments here!

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Discover more from TrendGrnd

Subscribe now to keep reading and get access to the full archive.

Continue reading